| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
The Board of Directors (the "Board") of ENDRA Life Sciences Inc. (the "Company") has authorized the Company to develop and pursue a cryptocurrency treasury strategy. Following this authorization, the Company has: (i) retained Anchorage Digital Bank, N.A., a U.S.-based, institutional-grade custodian, to hold cryptocurrency acquired by the Company in connection with its treasury strategy and (ii) engaged Arca Investment Management, LLC to manage the Company's cryptocurrency holdings and to implement a bitcoin-based income-generating strategy.
On July 23, 2025, in connection with the Company's cryptocurrency treasury strategy, the Board formed a Cryptocurrency Advisory Board (the "Advisory Board") to assist the Company in developing and managing its cryptocurrency treasury strategy. The Board appointed the following individuals to the Advisory Board:
| · | James Altucher, an entrepreneur, author, cryptocurrency advocate, and former hedge fund manager; | |
| · | James Manning, founder and CEO of Mawson Infrastructure Group, a U.S.-focused digital infrastructure provider; and | |
| · | Rayne Steinberg, co-founder and CEO of Arca Investment Management, LLC, an institutional-grade cryptocurrency asset management firm. |
Posted In: NDRA
